title: Advances in allergic skin disease: omalizumab is a promising therapy for urticaria and angioedema.
authors.forename: Sheldon L
authors.initials: SL
authors.lastname: Spector
authors.forename: Ricardo A
authors.initials: RA
authors.lastname: Tan
mesh_terms: D000707:Anaphylaxis / Q000453:epidemiology / Q000209:etiology / Q000276:immunology*; D000818:Animals; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity / Q000276:immunology*; D005512:Food Hypersensitivity / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D007299:Insect Bites and Stings / Q000276:immunology*; D012871:Skin Diseases / Q000209:etiology / Q000276:immunology* / Q000628:therapy